Bausch & Lomb (TSX:BLCO) Earnings per Share (Diluted) : C$-1.00 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Earnings per Share (Diluted)?

Bausch & Lomb's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was C$-0.20. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.00.

Bausch & Lomb's EPS (Basic) for the three months ended in Dec. 2023 was C$-0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.00.

Bausch & Lomb's EPS without NRI for the three months ended in Dec. 2023 was C$-0.10. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.73.

During the past 12 months, Bausch & Lomb's average EPS without NRIGrowth Rate was -1825.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -89.20% per year.

During the past 6 years, Bausch & Lomb's highest 3-Year average EPS without NRI Growth Rate was -36.10% per year. The lowest was -89.20% per year. And the median was -67.10% per year.

Bausch & Lomb Earnings per Share (Diluted) Historical Data

The historical data trend for Bausch & Lomb's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Earnings per Share (Diluted) Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

1.12

-0.06

0.67

0.03

-0.99

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial											-	-0.36	-0.12	-0.33	-0.20

Competitive Comparison of Bausch & Lomb's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's PE Ratio distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's PE Ratio falls into.

Bausch & Lomb Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Bausch & Lomb's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-348.816	-	0)	/	350.500
	=	-1.00

Bausch & Lomb's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-72.446	-	0)	/	350.800
	=	-0.21

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.00

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Bausch & Lomb (TSX:BLCO) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bausch & Lomb Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.